View in EDS

Gut microbiome is associated with recurrence-free survival in patients with resected high-risk melanoma receiving adjuvant immune checkpoint blockade.

Saved in:
Bibliographic Details
Title: Gut microbiome is associated with recurrence-free survival in patients with resected high-risk melanoma receiving adjuvant immune checkpoint blockade.
Authors: Usyk M; NYU Laura and Isaac Perlmutter Cancer Center, New York, NY, USA; Department of Population Health, NYU Grossman School of Medicine, New York, NY, USA; Departments of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, NY, USA; Departments of Pediatrics (Genetics), Albert Einstein College of Medicine, Bronx, New York, NY, USA., Hayes RB; NYU Laura and Isaac Perlmutter Cancer Center, New York, NY, USA; Department of Population Health, NYU Grossman School of Medicine, New York, NY, USA., Knight R; Departments of Pediatrics, Computer Science & Engineering, and Bioengineering, Center for Microbiome Innovation, University of California, San Diego, La Jolla, CA, USA., Gonzalez A; Departments of Pediatrics, Computer Science & Engineering, and Bioengineering, Center for Microbiome Innovation, University of California, San Diego, La Jolla, CA, USA., Li H; NYU Laura and Isaac Perlmutter Cancer Center, New York, NY, USA; Department of Population Health, NYU Grossman School of Medicine, New York, NY, USA., Osman I; NYU Laura and Isaac Perlmutter Cancer Center, New York, NY, USA; The Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, NY, USA; Department of Medicine, NYU Grossman School of Medicine, New York, NY, USA., Weber JS; NYU Laura and Isaac Perlmutter Cancer Center, New York, NY, USA; Department of Medicine, NYU Grossman School of Medicine, New York, NY, USA., Ahn J; NYU Laura and Isaac Perlmutter Cancer Center, New York, NY, USA; Department of Population Health, NYU Grossman School of Medicine, New York, NY, USA. Electronic address: jiyoung.ahn@nyulangone.org.
Source: Cell [Cell] 2026 Jun 25; Vol. 189 (13), pp. 3940-3949.e14. Date of Electronic Publication: 2026 Apr 17.
Publication Type: Journal Article; Clinical Trial, Phase III
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 0413066 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-4172 (Electronic) Linking ISSN: 00928674 NLM ISO Abbreviation: Cell Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41999744
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Gut microbiome is associated with recurrence-free survival in patients with resected high-risk melanoma receiving adjuvant immune checkpoint blockade.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Usyk+M%22">Usyk M</searchLink>; NYU Laura and Isaac Perlmutter Cancer Center, New York, NY, USA; Department of Population Health, NYU Grossman School of Medicine, New York, NY, USA; Departments of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, NY, USA; Departments of Pediatrics (Genetics), Albert Einstein College of Medicine, Bronx, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Hayes+RB%22">Hayes RB</searchLink>; NYU Laura and Isaac Perlmutter Cancer Center, New York, NY, USA; Department of Population Health, NYU Grossman School of Medicine, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Knight+R%22">Knight R</searchLink>; Departments of Pediatrics, Computer Science & Engineering, and Bioengineering, Center for Microbiome Innovation, University of California, San Diego, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Gonzalez+A%22">Gonzalez A</searchLink>; Departments of Pediatrics, Computer Science & Engineering, and Bioengineering, Center for Microbiome Innovation, University of California, San Diego, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Li+H%22">Li H</searchLink>; NYU Laura and Isaac Perlmutter Cancer Center, New York, NY, USA; Department of Population Health, NYU Grossman School of Medicine, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Osman+I%22">Osman I</searchLink>; NYU Laura and Isaac Perlmutter Cancer Center, New York, NY, USA; The Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, NY, USA; Department of Medicine, NYU Grossman School of Medicine, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Weber+JS%22">Weber JS</searchLink>; NYU Laura and Isaac Perlmutter Cancer Center, New York, NY, USA; Department of Medicine, NYU Grossman School of Medicine, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Ahn+J%22">Ahn J</searchLink>; NYU Laura and Isaac Perlmutter Cancer Center, New York, NY, USA; Department of Population Health, NYU Grossman School of Medicine, New York, NY, USA. Electronic address: jiyoung.ahn@nyulangone.org.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220413066%22">Cell</searchLink> [Cell] 2026 Jun 25; Vol. 189 (13), pp. 3940-3949.e14. <i>Date of Electronic Publication: </i>2026 Apr 17.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase III
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cell+Press%22">Cell Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0413066 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1097-4172 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200928674%22">00928674 </searchLink><i>NLM ISO Abbreviation: </i>Cell <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41999744
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.cell.2026.03.041
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 3940
    Titles:
      – TitleFull: Gut microbiome is associated with recurrence-free survival in patients with resected high-risk melanoma receiving adjuvant immune checkpoint blockade.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Usyk M
      – PersonEntity:
          Name:
            NameFull: Hayes RB
      – PersonEntity:
          Name:
            NameFull: Knight R
      – PersonEntity:
          Name:
            NameFull: Gonzalez A
      – PersonEntity:
          Name:
            NameFull: Li H
      – PersonEntity:
          Name:
            NameFull: Osman I
      – PersonEntity:
          Name:
            NameFull: Weber JS
      – PersonEntity:
          Name:
            NameFull: Ahn J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 25
              M: 06
              Text: 2026 Jun 25
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1097-4172
          Numbering:
            – Type: volume
              Value: 189
            – Type: issue
              Value: 13
          Titles:
            – TitleFull: Cell
              Type: main
ResultId 1